MCRB - Seres Therapeutics, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 656.13M
Enterprise value 712.30M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)116.89
Price/book (mrq)66.88
Enterprise value/revenue 139.31
Enterprise value/EBITDA -2.84

Trading information

Stock price history

Beta (5Y monthly) 2.62
52-week change 352.58%
S&P500 52-week change 31.77%
52-week high 39.4900
52-week low 32.5000
50-day moving average 35.5525
200-day moving average 35.9351

Share statistics

Avg vol (3-month) 32.93M
Avg vol (10-day) 32.3M
Shares outstanding 5127.9M
Implied shares outstanding 6N/A
Float 896.22M
% held by insiders 16.72%
% held by institutions 183.81%
Shares short (14 May 2023) 415.01M
Short ratio (14 May 2023) 42.76
Short % of float (14 May 2023) 422.28%
Short % of shares outstanding (14 May 2023) 411.74%
Shares short (prior month 13 Apr 2023) 48.95M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin 0.00%
Operating margin (ttm)-5,110.64%

Management effectiveness

Return on assets (ttm)-55.35%
Return on equity (ttm)-1,600.16%

Income statement

Revenue (ttm)5.11M
Revenue per share (ttm)0.04
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)-165.79M
EBITDA -254.85M
Net income avi to common (ttm)-264.71M
Diluted EPS (ttm)-2.2000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)106.54M
Total cash per share (mrq)0.83
Total debt (mrq)162.71M
Total debt/equity (mrq)N/A
Current ratio (mrq)1.82
Book value per share (mrq)-0.38

Cash flow statement

Operating cash flow (ttm)-238.96M
Levered free cash flow (ttm)-154.96M